In tumor-to-stroma signaling, primary and metastatic lesions are characterized by EFNA2 interacting with EPHA1, EFNB3 interacting with EPHB2, and EFNB3 interacting with EPHB6, among several others (Figure 1). Here, EFNB3 is linked to neoplasm.